Miguel Sena-Esteves received his PhD in biomedical sciences from the University of Porto, Portugal, where he started his work in gene therapy. His laboratory at UMMS focuses on the development of adeno-associated virus (AAV) based gene therapies and capsid engineering for Tay-Sachs disease, GM1-gangliosidosis, Huntington’s disease, ALS, and brain tumors.